Publications
Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)
Lancet Reg Health Eur. 2025; 53:101303. PMID: 40291400
Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
Clin Infect Dis. 2024; 79(1):215-222. PMID: 38568992.
Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study
Clin Infect Dis. 2022; 75(3):372-381. PMID: 34849642.
Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
Thorax. 2023; 78(3):288-296. PMID: 36283826.
The ability of the neonatal immune response to handle SARS-CoV-2 infection.
Lancet Child Adolesc Health. 2021; 5(3):e6-e7. PMID: 33484660.
Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe
Eur Respir J. 2021; 58(3):2101196. PMID: 34049946.
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study
Eur Respir J. 2020; 56(1):1902004. PMID: 32299859.
Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study.
Clin Infect Dis. 2020; 71(10):2561-2569. PMID: 31796965.
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Lancet Child Adolesc Health. 2020; 4(9):653-661. PMID: 32593339.
Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe.
Eur Respir J. 2018; 51(5):1800346. PMID: 29773607.
The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey.
Tuberculosis. 2016; 101:125-129. PMID: 27865381.
European shortage of purified protein derivative and its impact on tuberculosis screening practices.
Int J Tuberc Lung Dis. 2016; 20(10):1293-1299. PMID: 27725037.
Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
Vaccine. 2015 Sep 11; 33(38):4994-9. PMID: 26151543.
Tuberculosis in young refugees
Lancet. 2015; 386(10012):2475-6. PMID: 26738710.
Shortage of purified protein derivative for tuberculosis testing.
Lancet. 2014; 384(9959). PMID: 25483167.
Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europe.
PLoS One. 2014; 9(6):e99129. PMID: 24922084.
Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases.
Thorax. 2013; 68(6):588. PMID: 23128034.
Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study
Am J Respir Crit Care Med. 2012; 186(4):378-84. PMID: 22700862.